BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8486478)

  • 1. [Systemic lupus erythematosus].
    Schröder JO; Euler HH
    Internist (Berl); 1993 Apr; 34(4):351-61. PubMed ID: 8486478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N; Bambauer R; Jost W; Schäfer M
    Monatsschr Kinderheilkd; 1990 Jul; 138(7):395-8. PubMed ID: 2398909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis for lupus nephritis.
    Robinson JA
    N Engl J Med; 1992 Oct; 327(14):1028-9; author reply 1029-30. PubMed ID: 1472252
    [No Abstract]   [Full Text] [Related]  

  • 6. The therapeutic potential of plasmapheresis in systemic lupus erythematosus (SLE).
    Swaak AJ
    Neth J Med; 1988 Oct; 33(3-4):155-9. PubMed ID: 3226448
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of systemic lupus erythematosus].
    Ivanova MM
    Klin Med (Mosk); 1985 Jan; 63(1):16-23. PubMed ID: 3887016
    [No Abstract]   [Full Text] [Related]  

  • 8. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
    J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances and prospects in the treatment of systemic lupus erythematosus].
    Ivanova MM; Solov'ev SK
    Ter Arkh; 2009; 81(12):44-7. PubMed ID: 20481048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the outcome of lupus nephritis according to long-term treatment employing different modes of immunotherapy.
    Hashimoto H; Sugawara M; Tsuda H; Kabasawa K; Hirose S
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1003-9. PubMed ID: 1479728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus erythematosus; current treatment methods].
    Nossent JC
    Ned Tijdschr Geneeskd; 1993 Mar; 137(11):558. PubMed ID: 8464532
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selected aspects of therapy of systemic lupus erythematosus].
    Hiepe F; Apostoloff E
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):383-7. PubMed ID: 1615720
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of systemic lupus erythematosus].
    Börsch G; Neumann R; Ricken D
    Dtsch Med Wochenschr; 1983 May; 108(20):792-4. PubMed ID: 6840013
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal transplantation in patients with lupus nephritis: a single-center experience.
    Ghafari A; Etemadi J; Ardalan MR
    Transplant Proc; 2008; 40(1):143-4. PubMed ID: 18261571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculitis and vasculopathy in Lupus Nephritis: Clinical variability, outcome, and new insight into treatment.
    Kaul A; Agrawal V; Bhaduaria D; Agrawal V; Prasad N; Gupta A; Sharma RK
    Saudi J Kidney Dis Transpl; 2017; 28(2):415-424. PubMed ID: 28352031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic lupus erythematosus: from adolescence to adulthood].
    Mathian A; Amoura Z
    Arch Pediatr; 2010 Jun; 17(6):634-5. PubMed ID: 20654816
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of lupus nephritis: an update.
    Houssiau FA
    J Am Soc Nephrol; 2004 Oct; 15(10):2694-704. PubMed ID: 15466274
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of LED-nephritis].
    Mustonen J
    Duodecim; 1994; 110(11):1090-5. PubMed ID: 7588119
    [No Abstract]   [Full Text] [Related]  

  • 19. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose intravenous immunoglobulins: a new step in the treatment of systemic lupus erythematosus.
    Rauova L; Rovensky J; Shoenfeld Y
    Isr Med Assoc J; 2000 May; 2(5):388-92. PubMed ID: 10892397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.